Dementia-free adults aged 40–69 years from UK Biobank
Care Setting
Population-based cohort study; potential implications for preventive strategies
Key Highlights
Identified 83 metabolites representing healthy lifestyle behaviors via elastic net regression in 136,628 dementia-free participants.
Metabolic signature inversely associated with incident dementia risk over 12.55 years; hazard ratio 0.89 per SD increment for all-cause dementia.
Structural brain reserve (hippocampus, parahippocampal gyrus, middle temporal gyrus) mediates 6.21% to 11.98% of the metabolic signature's effect on dementia risk.
Guideline-Based Recommendations
Diagnosis
Use metabolic profiling as an objective measure to assess adherence to healthy lifestyle behaviors related to dementia risk.
Management
Promote multifactorial healthy lifestyle behaviors including non-smoking, moderate alcohol consumption, healthy diet, regular exercise, adequate sleep, non-sedentary behavior, and social interaction to reduce dementia risk.
Monitoring & Follow-up
Monitor metabolic signatures through high-throughput metabolomic profiling to evaluate lifestyle adherence and potential dementia risk.
Assess structural brain reserve via imaging-derived phenotypes to understand mediation of dementia risk.
Risks
Recognize that variations in metabolic response to lifestyle behaviors may influence individual dementia risk.
Consider biological heterogeneity when interpreting lifestyle effects on dementia risk.
Patient & Prescribing Data
Middle-aged to older adults without dementia or cancer at baseline
Healthy lifestyle adherence reflected by metabolic signature is associated with lower risk of all-cause and vascular dementia; metabolic profiling may guide personalized preventive interventions.
Clinical Best Practices
Encourage comprehensive lifestyle modifications rather than isolated behaviors to synergistically reduce dementia risk.
Utilize metabolomic profiling to objectively quantify lifestyle adherence and metabolic health.
Incorporate brain imaging assessments to evaluate structural brain reserve as a mediator of dementia risk.
Apply Mendelian randomization findings to support causal inference between metabolites and dementia risk.
